- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Silicon-based ultrasound generates images
Sensant has created the first clinical images using a novel ultrasound technology that uses silicon-based transducers. The images of the carotid artery, breast, and musculoskeletal system were presented for comparison with conventionally made images at
Sensant has created the first clinical images using a novel ultrasound technology that uses silicon-based transducers. The images of the carotid artery, breast, and musculoskeletal system were presented for comparison with conventionally made images at the 10th Congress of the World Federation for Ultrasound in Medicine and Biology in Montreal June 1 to 4. The Montreal-based company generated images in collaboration with staff from Esaote and radiologists at the Valduce Hospital in Como, Italy. Sensant claims its images rival those produced by state-of-the-art ultrasound systems, which rely on piezoelectric crystal technology. The tiny silicon structures, known as capacitive microfabricated ultrasonic transducers, provide superior acoustic response, according to Sensant (SCAN 1/2/03).
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
Assessing MACE Risk in Women: Can an Emerging Model with SPECT MPI Imaging Have an Impact?
December 9th 2024In research involving over 2,200 women who had SPECT MPI exams, researchers found that those who had a high score with the COronary Risk Score in WOmen (CORSWO) model had a greater than fourfold higher risk of major adverse coronary events (MACE).
